Drugs in clinical development for multiple sclerosis: Focusing on anti-CD20 antibodies
Trc khi s dng bt k sn phm no, bn nn c k thng tin t nh sn xut trong t hng dn s dng v tham kho kin ca bc s hoc dc s
According to Ipsen, NAPOLI 3 is the first positive Phase III trial in mPDAC to show better OS compared to the current standard-of-care regimen, which consists of nab-paclitaxel and gemcitabine
Xu H, Zhang B, Chen Y, et al
Once inside the cell, these glucose molecules are then used to produce energy after passing through a series of chemical reactions, while the excess glucose is stored in liver as glycogen
Basicamente, eles foram testados em animais, mas no em seres humanos." Taylor vem acompanhando o crescimento deste mercado h mais de um ano